Rep. Josh Gottheimer Buys Ambev S.A. (NYSE:ABEV) Stock

Representative Josh Gottheimer (D-New Jersey) recently bought shares of Ambev S.A. (NYSE:ABEV). In a filing disclosed on February 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Ambev stock on January 27th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.

Representative Josh Gottheimer also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Visa (NYSE:V) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Mastercard (NYSE:MA) on 1/31/2025.
• Purchased $1,001 – $15,000 in shares of Visa (NYSE:V) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of 3M (NYSE:MMM) on 1/30/2025.

Ambev Price Performance

Shares of Ambev stock opened at $1.86 on Wednesday. Ambev S.A. has a twelve month low of $1.76 and a twelve month high of $2.72. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.89 and a current ratio of 1.20. The firm has a market cap of $29.22 billion, a P/E ratio of 10.31, a price-to-earnings-growth ratio of 5.56 and a beta of 1.04. The firm’s 50-day simple moving average is $1.94 and its 200-day simple moving average is $2.16.

Ambev Cuts Dividend

The firm also recently disclosed an annual dividend, which was paid on Thursday, January 9th. Stockholders of record on Monday, December 23rd were paid a $0.0414 dividend. This represents a dividend yield of 1.93%. The ex-dividend date of this dividend was Monday, December 23rd. Ambev’s dividend payout ratio is 38.89%.

Institutional Trading of Ambev

A number of large investors have recently bought and sold shares of the business. Creative Planning lifted its holdings in shares of Ambev by 10.5% in the second quarter. Creative Planning now owns 259,335 shares of the company’s stock valued at $532,000 after purchasing an additional 24,678 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in Ambev in the 2nd quarter valued at approximately $225,000. SG Americas Securities LLC lifted its stake in Ambev by 546.9% in the 3rd quarter. SG Americas Securities LLC now owns 69,383 shares of the company’s stock valued at $169,000 after acquiring an additional 58,657 shares in the last quarter. Park Avenue Securities LLC boosted its position in Ambev by 23.8% during the 3rd quarter. Park Avenue Securities LLC now owns 28,787 shares of the company’s stock worth $70,000 after acquiring an additional 5,526 shares during the last quarter. Finally, Atomi Financial Group Inc. grew its stake in shares of Ambev by 54.9% during the 3rd quarter. Atomi Financial Group Inc. now owns 71,681 shares of the company’s stock worth $175,000 after acquiring an additional 25,409 shares in the last quarter. 8.13% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ABEV. StockNews.com began coverage on Ambev in a report on Monday, January 27th. They set a “buy” rating for the company. Citigroup restated a “neutral” rating on shares of Ambev in a research report on Wednesday, January 22nd. Bank of America cut shares of Ambev from a “buy” rating to a “neutral” rating in a research report on Friday, January 17th. Finally, Barclays cut their target price on Ambev from $2.50 to $2.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 21st. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Ambev currently has a consensus rating of “Hold” and an average price target of $2.45.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.

Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.

Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.

Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s, and Kokanee brands.